Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Current Assets (2020 - 2025)

BioAtla's Current Assets history spans 6 years, with the latest figure at $8.0 million for Q4 2025.

  • For Q4 2025, Current Assets fell 84.36% year-over-year to $8.0 million; the TTM value through Dec 2025 reached $8.0 million, down 84.36%, while the annual FY2025 figure was $8.0 million, 84.36% down from the prior year.
  • Current Assets reached $8.0 million in Q4 2025 per BCAB's latest filing, down from $9.7 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $273.5 million in Q3 2021 to a low of $8.0 million in Q4 2025.
  • Average Current Assets over 5 years is $138.6 million, with a median of $161.4 million recorded in 2023.
  • Peak YoY movement for Current Assets: grew 2.75% in 2021, then tumbled 84.36% in 2025.
  • A 5-year view of Current Assets shows it stood at $247.3 million in 2021, then decreased by 10.86% to $220.4 million in 2022, then plummeted by 47.19% to $116.4 million in 2023, then crashed by 55.99% to $51.2 million in 2024, then plummeted by 84.36% to $8.0 million in 2025.
  • Per Business Quant, the three most recent readings for BCAB's Current Assets are $8.0 million (Q4 2025), $9.7 million (Q3 2025), and $20.6 million (Q2 2025).